Best Hospitals for Astigmatism Treatment in Mumbai, India

Risks to be aware of

Astigmatism surgery is among the safest elective procedures in medicine, with serious sight-threatening complications occurring in fewer than 1 in 5,000 cases at accredited centres. However, patients must be counselled on the following procedure-specific risks with full transparency: LASIK-specific: Flap complications (incomplete flap, buttonhole, free cap) occur in < 0.5% with femtosecond laser creation vs. 1–2% with microkeratome. Diffuse lamellar keratitis (DLK, 'Sands of the Sahara') presents in the first post-operative week as interface inflammation; managed with intensive topical steroids (Grade 1–2) or flap irrigation (Grade 3–4). Epithelial ingrowth under the flap is rare (< 1%) and typically self-limiting. Post-LASIK ectasia: The most feared complication; risk is reduced to near zero when Belin-Ambrosio Enhanced Ectasia Display (BAD-D score) and Ectasia Risk Score System (ERSS) screening protocols are strictly followed. Residual stromal bed < 250 µm and unrecognised sub-clinical keratoconus are the primary risk factors. Dry eye disease exacerbation: Clinically significant dry eye occurs in 10–20% of LASIK patients at 1 month, resolving in most by 6 months as corneal nerves regenerate. SMILE demonstrates significantly lower dry eye incidence due to preservation of subbasal nerve plexus. Pre-operative OSDI score, Schirmer, and meibomian gland assessment should identify high-risk patients who may be better served by Trans-PRK with intensive lubrication protocols. Regression and under/over-correction: Approximately 3–5% of patients require an enhancement procedure, particularly those with high initial astigmatism (> −3.00 D) or surface ablation procedures. Patients must have adequate residual stromal tissue for retreatment (minimum 250 µm residual stroma post-primary ablation). ICL-specific risks: Pupillary block glaucoma is essentially eliminated by the EVO+ central port design. Cataract formation (anterior subcapsular opacity from lens contact) is reported in < 1% with correct vault targeting. Endothelial cell loss is the primary long-term concern: published 10-year data show approximately 7–10% cumulative loss, remaining within safe limits if pre-operative count was ≥ 2,400 cells/mm². Biennial specular microscopy is mandatory. RLE/Toric IOL risks: Risks mirror standard cataract surgery — posterior capsule rupture (< 1%), posterior capsule opacification requiring Nd:YAG laser capsulotomy (20–30% at 5 years), cystoid macular oedema (< 1%), and toric IOL rotational misalignment (> 10° rotation degrades astigmatic correction; requires surgical re-rotation within 2–4 weeks). Photic phenomena (halos, glare, starbursts) are more pronounced with multifocal/trifocal toric platforms and require careful patient selection and counselling. General considerations across all procedures: Night vision disturbances (halos and starbursts around lights) are most common in the first 3–6 months, particularly if pupil diameter exceeds the optical zone. Patients in night-critical professions (airline pilots, surgeons, night-shift drivers) should be counselled about this with detailed wavefront simulation. All risks are substantially mitigated by rigorous pre-operative screening — the cornerstone of GAF Healthcare's patient selection protocol.